RaQualia Pharma, Inc.

19
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3967150008
JPY
1,212.00
-94 (-7.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
3,107.00
1,901.00
2,918.00
2,776.00
1,107.00
1,702.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3,107.00
1,901.00
2,918.00
2,776.00
1,107.00
1,702.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
184.00
6.00
5.00
1.00
0.00
0.00
General and Administration Expenses
780.00
613.00
565.00
614.00
517.00
587.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,320.00
2,238.00
2,051.00
2,068.00
1,593.00
1,718.00
Operating Profit (PBDIT) excl Other Income
-213.00
-337.00
866.00
707.00
-486.00
-15.00
Other Income
63.00
71.00
55.00
184.00
-39.00
39.00
Operating Profit (PBDIT)
251.00
-90.00
1,069.00
1,033.00
-401.00
163.00
Interest
184.00
6.00
5.00
1.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
401.00
175.00
147.00
141.00
124.00
140.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-357.00
-294.00
851.00
880.00
-527.00
27.00
Provision for Tax
137.00
29.00
127.00
124.00
79.00
21.00
Profit After Tax
-495.00
-323.00
723.00
755.00
-606.00
5.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-22.87
-14.98
34.47
36.04
-28.97
0.26
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 63.45% vs -34.85% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 36.75% vs -138.95% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 2,655.79% vs 11.44% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -52.95% vs -144.74% in Dec 2023

Compare Profit and Loss Results of RaQualia Pharma, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
3,107.00
0.00
3,107.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,107.00
0.00
3,107.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
31.00
-31.00
-100.00%
Operating Expenses
184.00
0.00
184.00
0%
General and Administration Expenses
780.00
191.00
589.00
308.38%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,320.00
1,174.00
2,146.00
182.79%
Operating Profit (PBDIT) excl Other Income
-213.00
-1,174.00
961.00
81.86%
Other Income
63.00
53.00
10.00
18.87%
Operating Profit (PBDIT)
251.00
-1,208.00
1,459.00
120.78%
Interest
184.00
0.00
184.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
401.00
0.00
401.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-357.00
-1,208.00
851.00
70.45%
Provision for Tax
137.00
1.00
136.00
13,600.00%
Profit After Tax
-495.00
-1,209.00
714.00
59.06%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-22.8742
-67.9005
45.03
66.31%
Profit And Loss - Net Sales
Net Sales 3,107.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 63.45% vs -34.85% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -213.38 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.75% vs -138.95% in Dec 2023

Profit And Loss - Interest
Interest 184.11 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2,655.79% vs 11.44% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax -495.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -52.95% vs -144.74% in Dec 2023